Loading...
Images of Roberto Guerciolini
(0 from 0 )1
0
0
News
Pharmakotherapie der Adipositas: Gezielte Inhibition von Lipasen
www.aerzteblatt.de
Nach Angaben von Dr. Roberto Guerciolini (Hoffmann-La Roche) erklärt sich der Wirkmechanismus der Substanz folgendermaßen: THL ist ein starker und ...
RNA interference seen as next step in fighting macular degeneration
www.healio.com
Ocular Surgery News | With drugs that inhibit vascular endothelial growth factor showing promise in the treatment of wet age-related macular degeneration, some...
Telephone & Addresses
Roberto Guerciolini, 61, Weston, US, …nt Rd
View Roberto's social profiles and photos on Facebook, MySpace, and +40 Networks.
Roberto E Guerciolini, 61, Boulder, US, Racquet Ln
View Roberto's social profiles and photos on Facebook, MySpace, and +40 Networks.
WhitePages: Roberto Guerciolini | Whitepages
There are no people in the US/Canada named Roberto Guerciolini. Whitepages is the largest and most trusted directory, and has contact information for over ...
Network Profiles
LinkedIn: Roberto Guerciolini - Schweiz | LinkedIn
Sehen Sie sich das Karriere-Profil von Roberto Guerciolini (Schweiz) auf LinkedIn an. Berufserfahrung von Roberto Guerciolini: PGM, GI/Inflammation, Shire
Roberto Guerciolini Net Worth (2020) | wallmine
wallmine.com
The estimated Net Worth of Roberto Guerciolini is at least $32.4 Thousand dollars as of 7 December Roberto Guerciolini owns over 24,000 units of Wave Life Sciences stock worth over $32,360 and over the last 4 years Roberto sold WVE stock worth over $0.
Interests
Roberto Guerciolini - Patents
www.freshpatents.com
Roberto Guerciolini patents Recent bibliographic sampling of Roberto Guerciolini patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title): Archived* (*May have duplicates - we are upgrading our archive.)
American Journal of Opthalmology - Vol n° 1 - EM consulte
www.em-consulte.com
Le site de référence en informations médicales et paramédicales - EM|consulte
Biotech Values: More on Sirna ‘s surprisingly strong AMD
investorshub.advfn.com
Dr. Roberto Guerciolini, chief medical officer of the tiny San Francisco-based biotechnology company, said the Phase I data involved
Education
Roberto Guerciolini - Biography - …
www.marketscreener.com
Become a member for free. Sign up. Sign up
Books & Literature
The Revolution Starts Here
library.corporate-ir.net
SIRNA-027 PHASE 1 CLINICAL TRIAL: VISUAL ACUITY AT 8 WEEKS. ON A SINGLE DOSE. Roberto Guerciolini, M.D.. Senior Vice President ...
Carboxylic Ester Hydrolases—Advances in Research and Application:...
books.google.co.il
Carboxylic Ester Hydrolases—Advances in Research and Application: Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and...
Obesity: New Insights for the Healthcare Professional: Edition -...
books.google.co.il
Obesity: New Insights for the Healthcare Professional: Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive...
Plunkett's Biotech & Genetics Industry Almanac 2006: The Only...
books.google.co.il
Plunkett's Biotech & Genetics Industry Almanac is a complete reference guide to the business side of biotechnology, genetics, proteomics and related services....
Related Documents
Comparative Evaluation of Fecal Fat Excretion Induced by Orlistat and...
www.proquest.com
Induced by Orlistat and Chitosan. Roberto Guerciolini,* Lucian Radu-Radulescu,* Mark Boldrin,† Jayson Dallas,‡ and Rema Moore§. Abstract. GUERCIOLINI ...
SEC Info - Guerciolini Roberto - ‘3’ for re: Wave Life...
www.secinfo.com
Guerciolini Roberto - ‘3’ for re: Wave Life Sciences Ltd. - EX Initial Statement of Beneficial Ownership of Securities - Seq EX-24 Document...
THURSDAY, SEPTEMBER 15, :30 AM – 7:30 PM Registration ...
www.myotonic.org
3:15 – 4:00 PM. Early Stage DM Therapy Development Update. Matt Disney, PhD; Roberto Guerciolini, MD; Lauren Wood, PhD. 4:15 – 5:00 PM.
Scientific Publications
Cephalosporin-Induced Hypoprothrombinemia: Is the N ...
www.ncbi.nlm.nih.gov
GIANCARLO AGNELLI,'* ALBANO DEL FAVERO,1 PASQUALE PARISE,2 ROBERTO GUERCIOLINI,1. BRUNA PASTICCI,3 GIUSEPPE G.
Roberto Guerciolini – ScienceOpen
www.scienceopen.com
To determine the maximum-tolerated dose (MTD), dose-limiting toxicity (DLT), and pharmacodynamics (PD) of the proteasome inhibitor bortezomib (previously ...
Miscellaneous
Roberto Guerciolini | LinkedIn
www.linkedin.com
View Roberto Guerciolini's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Roberto Guerciolini ...
EP A2 - Rna interference mediated inhibition of hepatitis c...
patents.google.com
... PCT/US , PCT/US , PCT/US Inventors, James Mcswiggen, David Morrissey, Roberto Guerciolini, Chandra Vargeese, Vasant Jadhav.
WO A2 - RNA INTERFERENCE MEDIATED INHIBITION OF VASCULAR...
patents.google.com
Inventors, James Mcswiggen, Roberto Guerciolini, Pamela Cited Patent
Filing date
Publication date
Applicant
WO A2
20 Feb Aug Leonid Beigelman
WO A2
24 May Mar Vasant Jadhav
Roberto Guerciolini | GenomeWeb
www.genomeweb.com
Dicerna, an RNAi drug startup based in Boston (see related story, this issue), has appointed Roberto Guerciolini as seni
Wave Life Sciences Appoints Roberto Guerciolini, M.D., As Senior Vice...
www.biospace.com
Wave Life Sciences Appoints Roberto Guerciolini, M.D., As Senior Vice President And Head Of Early Development - read this article along with other careers...
WO A3 - Rna interference mediated inhibition of hepatitis c...
patents.google.com
Buluş Sahipleri, Roberto Guerciolini, Vasant Jadhav, James Mcswiggen, David Morrissey, Chandra Vargeese. Başvuru sahibi, Roberto Guerciolini, Vasant ...
RNAi-Based Treatment for Neovascular Age-Related Macular Degeneration...
experts.nebraska.edu
... Shah ; Edward J. Quinlan ; Homayoun Tabandeh ; Diana V. Do ; Gail Reisen ; Jennifer A. Lockridge ; Brian Short ; Roberto Guerciolini ; Quan Dong Nguyen.
Silicon Investor (SI) -- The First Internet Community
www.siliconinvestor.com
Roberto Guerciolini [There appears to be a fair number of people leaving Millennium for whatever reasons. Guerciolini seems to have found ...
Sirna drug helps vision in blindness-risk patients
www.3-rx.com
Sirna drug helps vision in blindness-risk patients. Eye / Vision Problems
Wave Life Sciences Ltd. (WVE) - Insider Monkey
www.insidermonkey.com
Roberto Guerciolini, See Remarks, ; Keith Regnante, Chief Financial Officer, ; A. Michael Panzara, Franchise Lead, Neurology,
Related search requests for Roberto Guerciolini
|
People Forename "Roberto" (36186) Name "Guerciolini" (1) |
sorted by relevance / date